Pomerantz LLP

Company

Last mentioned: Jul 20, 2026

Share

Across the most recent 11 stories covering Pomerantz LLP — 27% negative, 73% neutral sentiment, averaging 5.3/10 impact.

This entity profile aggregates every story where the entity meets our minimum relevance threshold before it is linked here — a story naming this entity only in passing, as competitive context for an unrelated subject, does not qualify. That threshold exists because earlier testing surfaced entity pages cluttered with tangential mentions: a story about two unrelated companies merging could otherwise populate a third company's page simply because it was named once for comparison, with no real event of its own. The timeline below reflects genuine milestones and developments specific to this entity, cross-referenced against the same source-verification standard applied to every story on this site. Sentiment measures the directional read of each development for this entity specifically, not the overall tone of the reporting, and impact weights how consequential a development is rather than how widely it was syndicated across outlets.

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

Timeline

  1. Discovery Phase

    Expected commencement of the discovery process if the cases survive initial motions to dismiss.

  2. Pomerantz LLP Announces Investigations

    Pomerantz issues press releases for all five companies, seeking lead plaintiffs for potential securities class actions.

  3. Celsius Texas AG Investigation

    Texas AG Paxton announces investigation into Celsius's marketing of high-caffeine drinks to children. Stock falls 7.53%.

  4. Compass Antitrust Probe Disclosure

    Media reports NY AG antitrust investigation into Compass's $1.6B acquisition of Anywhere Real Estate. Stock falls 11.82%.

  5. Wise Money Laundering Report

    The Bureau of Investigative Journalism reports Belgian probe into Wise accounts used for money laundering. Stock falls 4.63% on June 2.

  6. Photronics Q2 Earnings Miss

    Photronics reports Q2 revenue of $209M, down YoY, and operating margin contraction. Stock falls 36.4%.

  7. Gap Inc. Q1 Earnings Miss

    Gap reports Q1 revenue of $3.5B, 1% growth YoY, missing estimates; cuts full-year guidance. Stock falls 15.4% on May 29.

  8. Verra Mobility contract termination disclosure

    Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.

  9. Lead Plaintiff Deadline

    Estimated deadline for shareholders to petition the court to lead the litigation.

  10. Lead Plaintiff Deadline

    Final date for investors to apply for lead plaintiff status in the litigation.

  11. GeneDx Q1 2026 results

    Adjusted gross margin 74%→69%, FY revenue guide cut to $475–$490M from $540–$555M, and $31.3M impairment on Fabric Genomics. Stock drop implied.

  12. Badger Meter Q1 2026 results

    EPS of $0.93 missed by $0.26, revenue of $202.03M missed by $28.58M; utility water sales -10% YoY. Stock fell 24.13% to $115.54.

  13. Lead Plaintiff Deadline (Est)

    Anticipated deadline for shareholders to move the court for lead plaintiff appointment.

  14. Secondary Notice

    Pomerantz reinforces the filing highlights to ensure broad investor awareness.

  15. Snowflake Filing

    Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.

  16. Legal Alerts

    Pomerantz LLP issues shareholder alerts for Driven Brands, CWH, and Apollo.

  17. Enphase Suit Filed

    Pomerantz LLP files class action litigation against Enphase Energy in federal court.

  18. Legal Reminders Issued

    Pomerantz LLP issues formal reminders to shareholders of MREO and RR regarding active litigation.

  19. Initial Legal Notice

    Pomerantz LLP issues the first public call for shareholders to join the class action.

  20. Pomerantz LLP Action

    Pomerantz LLP formally advises shareholders of the class action filing.

Stories mentioning Pomerantz LLP 11

Corporate Law Neutral

Pomerantz LLP Targets Mereo BioPharma and Richtech Robotics in Class Actions

Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Mereo BioPharma and Richtech Robotics, signaling a surge in securities litigation within the biotech and automation sectors. These legal actions focus on alleged violations of federal securities laws, specifically regarding material misstatements that impacted investor valuations.

2 sources

Source: pr-inside.com · pr-inside.com

Corporate Law Neutral

Pomerantz LLP Targets monday.com and Trip.com in Dual Securities Class Actions

Pomerantz LLP has initiated securities class action proceedings against SaaS leader monday.com and global travel platform Trip.com, alleging violations of federal securities laws. The firm is currently advising shareholders on lead plaintiff deadlines following claims of misleading corporate disclosures that impacted market valuations.

3 sources

Source: pr-inside.com · pr-inside.com

About Pomerantz LLP coverage

This page surfaces every story mentioning Pomerantz LLP across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.

Entities only appear on this page once the classifier scores them at a minimum 35 percent relevance to the story, filtering out passing mentions. According to that methodology, reviewed July 2026, this follows multi-source corroboration standards recommended by journalism research bodies such as the Reuters Institute for the Study of Journalism.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.

What you seeWhat it tells you
Story countNumber of distinct stories where Pomerantz LLP was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.